Bioretec Ltd to raise funds through a new rights issue for strategic initiatives.
- Bioretec Ltd aims to raise EUR 14.8 million
- Rights issue to fund strategic initiatives
- Terms and conditions published
Bioretec Ltd's board has announced a rights issue to raise up to approximately EUR 14.8 million. This financial move aims to support the company's strategic initiatives and overall growth. The rights issue will provide existing shareholders the opportunity to acquire additional shares at a predetermined price.
The terms and conditions related to the rights issue have been published, detailing the mechanisms by which shareholders can participate. This initiative reflects Bioretec's commitment to enhancing its capital structure and ensuring adequate resources for ongoing projects. The funds raised are anticipated to strengthen the company's position in the healthcare market.
This rights issue serves as a crucial step for Bioretec Ltd as it looks to bolster its financial foundation while simultaneously engaging its shareholder base. The process will allow existing investors to maintain their ownership percentage by purchasing additional shares in the company.
